Embark Behavioral Health, Clinical Social Work/Therapist, Chandler, AZ, 85226, (623) 343-6129, Our therapists are committed to providing your family with the most accessible online therapy to help ...

Embark Behavioral Health operates an exceptional network of treatment and therapy programs across the United States. We specialize in preteens, teens, and young adults, struggling with anxiety ...

Cybin Inc., a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the ...

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years in patients with Duchenne muscular dystrophy (DMD).

Encouraging long-term outcomes were seen in patients with Duchenne muscular dystrophy (DMD) who received the gene therapy delandistrogene moxeparvovec (Elevidys; Sarepta) in the EMBARK trial ...

CAMBRIDGE, Mass., May 16, 2025--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today presented new data from Part 2 of the EMBARK study that ...

Cybin Announces EMBARK Open Access, the First Free Online Course Providing Facilitator Training for Psychedelic Therapy. April 12, 2023 07:30 AM Eastern Daylight Time. TORONTO-- ...

About EMBARK, Study SRP-9001-301. Study SRP-9001-301, also known as EMBARK, is a multinational, phase 3, randomized, two-part crossover, placebo-controlled study of ELEVIDYS in individuals with ...